1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Frequency of TP and FP sources of enhancement for each SPACE, MPRAGE, VIBE sequence, and blind readers
SPACEMPRAGEVIBEPa (SPACE vs MPRAGE)Pa (SPACE vs VIBE)
TP enhancement sources (No. of patients)
    ER 150 (19)44 (16)42 (15).070.042b
    ER 253 (15)42 (15)41 (15).026b.008b
    BR42 (14)34 (13)36 (12).006b.016b
FP enhancement sources (No. of patients)
    ER 122 (20)8 (6)8 (7).004b.008b
    ER 224 (23)7 (7)9 (8).004b.006b
    BR31 (28)6 (6)11 (11)<.001b.006b
  • ↵a McNemar test.
  • ↵b Statistically significant results.